Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036742 | SCV000060397 | likely benign | not specified | 2012-11-07 | criteria provided, single submitter | clinical testing | 4160+7A>G in intron 31 of RYR2: This variant is not expected to have clinical si gnificance because it is not located within the invariant +/- 1, 2 region. It ha s been identified in 1/8184 European American chromosomes from a broad populatio n by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/). 41 60+7A>G in intron 31 of RYR2 (allele frequency= 1/8184) ** |
Eurofins Ntd Llc |
RCV000726257 | SCV000343221 | uncertain significance | not provided | 2016-07-15 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002513420 | SCV001696804 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2024-10-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000726257 | SCV001742096 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000726257 | SCV001928723 | likely benign | not provided | no assertion criteria provided | clinical testing |